In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...